Old Web
English
Sign In
Acemap
>
authorDetail
>
Angela Tang
Angela Tang
Bristol-Myers Squibb
Saxagliptin
Pharmacokinetics
Medicine
Pharmacology
Internal medicine
4
Papers
119
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Influence of Renal or Hepatic Impairment on the Pharmacokinetics of Saxagliptin
2011
Clinical Pharmacokinectics
David W. Boulton
Li Li
Ernst U. Frevert
Angela Tang
Lorna Castaneda
Nimish N. Vachharajani
David M. Kornhauser
Chirag G. Patel
Show All
Source
Cite
Save
Citations (85)
Bioequivalence of Saxagliptin/Metformin Immediate Release (IR) Fixed-Dose Combination Tablets and Single-Component Saxagliptin and Metformin IR Tablets in Healthy Adult Subjects
2011
Clinical Drug Investigation
Vijay V. Upreti
Chi-Fung Keung
David W. Boulton
Ming Chang
Li Li
Angela Tang
Bonnie Hsiang
Donette Quamina‐Edghill
Ernst U. Frevert
Frank LaCreta
Show All
Source
Cite
Save
Citations (18)
P0586 A COMPARISON OF THE SINGLE-DOSE PHARMACOKINETICS AND SAFETY OF SAXAGLIPTIN IN SUBJECTS WITH HEPATIC IMPAIRMENT AND IN HEALTHY SUBJECTS
2009
European Journal of Internal Medicine
David W. Boulton
Angela Tang
Chirag G. Patel
Lorna Castaneda
Uli Frevert
Li Li
David M. Kornhauser
Show All
Source
Cite
Save
Citations (6)
Pharmacokinetics of the dipeptidyl peptidase-4 inhibitor saxagliptin in subjects with renal impairment
2009
David W. Boulton
Angela Tang
Chirag G. Patel
Li
Xiaohui Xu
Ernst U. Frevert
David M. Kornhauser
Show All
Source
Cite
Save
Citations (10)
1